These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1274 related items for PubMed ID: 17660238

  • 1. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 2. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 3. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I A receptor mRNAs in granulosa cells of preovulatory follicles of the rat ovary.
    Koh PO, Kwak SD, Kang SS, Cho GJ, Chun SY, Kwon HB, Choi WS.
    Mol Reprod Dev; 2000 Apr; 55(4):379-86. PubMed ID: 10694744
    [Abstract] [Full Text] [Related]

  • 4. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC.
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [Abstract] [Full Text] [Related]

  • 5. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 6. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B.
    J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876
    [Abstract] [Full Text] [Related]

  • 7. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
    Ko C, Park-Sarge OK.
    Biochem Biophys Res Commun; 2000 Oct 14; 277(1):270-9. PubMed ID: 11027674
    [Abstract] [Full Text] [Related]

  • 8. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar 14; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun 14; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 10. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, Jégou S.
    Neuroscience; 2006 Nov 17; 143(1):155-63. PubMed ID: 16962718
    [Abstract] [Full Text] [Related]

  • 11. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L.
    J Endocrinol; 2008 Feb 17; 196(2):291-303. PubMed ID: 18252952
    [Abstract] [Full Text] [Related]

  • 12. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb 17; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 13. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B.
    J Comp Neurol; 2006 Jun 01; 496(4):468-78. PubMed ID: 16572459
    [Abstract] [Full Text] [Related]

  • 14. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
    Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI.
    J Comp Neurol; 2004 Aug 30; 476(4):388-413. PubMed ID: 15282712
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA.
    Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463
    [Abstract] [Full Text] [Related]

  • 16. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.
    Mol Cell Neurosci; 2006 Feb 01; 31(2):193-209. PubMed ID: 16226889
    [Abstract] [Full Text] [Related]

  • 17. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 01; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 18. PACAP and VIP prevent apoptosis in schwannoma cells.
    Castorina A, Tiralongo A, Giunta S, Carnazza ML, Rasi G, D'Agata V.
    Brain Res; 2008 Nov 19; 1241():29-35. PubMed ID: 18835258
    [Abstract] [Full Text] [Related]

  • 19. Characterization, expression, and functional activity of pituitary adenylate cyclase-activating polypeptide and its receptors in human granulosa-luteal cells.
    Morelli MB, Barberi M, Gambardella A, Borini A, Cecconi S, Coticchio G, Canipari R.
    J Clin Endocrinol Metab; 2008 Dec 19; 93(12):4924-32. PubMed ID: 18782879
    [Abstract] [Full Text] [Related]

  • 20. Cellular localization of PACAP and its receptors in the ovary of the spotted ray Torpedo marmorata Risso 1880 (Elasmobranchii: Torpediniformes).
    Agnese M, Valiante S, Laforgia V, Andreuccetti P, Prisco M.
    J Exp Zool A Ecol Genet Physiol; 2013 Jan 19; 319(1):1-9. PubMed ID: 23027597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.